Brief: Oryzon Receives Japanese Patent Office Grant Decision
Feb 2 (Reuters) - Oryzon Genomics SA ORY.MC: RECEIVES JAPANESE PATENT OFFICE GRANT DECISION PATENT COVERS METHODS OF TREATING BEHAVIOR ALTERATIONS WITH VAFIDEMSTAT PREPARING A PHASE III TRIAL TO EVALUATE VAFIDEMSTAT FOR TREATMENT OF AGGRESSION IN BORDERLINE PERSONALITY DISORDER PREPARING PHASE II TRIAL IN AGGRESSION IN AUTISM SPECTRUM DISORDER PATIENTS Source text Further company coverage: ORY.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28